Rho Kinase Regulates Aortic Vascular Smooth Muscle Cell Stiffness Via Actin/SRF/Myocardin in Hypertension.
Rho Kinase Regulates Aortic Vascular Smooth Muscle Cell Stiffness Via Actin/SRF/Myocardin in Hypertension.
复制标题
Rho 激酶在高血压中通过肌动蛋白/SRF/心肌素调节主动脉血管平滑肌细胞僵硬度。
DOI:
10.1159/000485284
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
Qiu H
中科院分区:
文献类型:
--
作者:
Zhou N;Lee JJ;Stoll S;Ma B;Costa KD;Qiu H
Our previous studies demonstrated that intrinsic aortic smooth muscle cell (VSMC) stiffening plays a pivotal role in aortic stiffening in aging and hypertension. However, the underlying molecular mechanisms remain largely unknown. We here hypothesized that Rho kinase (ROCK) acts as a novel mediator that regulates intrinsic VSMC mechanical properties through the serum response factor (SRF)/myocardin pathway and consequently regulates aortic stiffness and blood pressure in hypertension. Four-month old male spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats were studied. Aortic stiffness was measured by echography. Intrinsic mechanical properties of VSMCs were measured by atomic force microscopy (AFM) in vitro. Compared to WKY rats, SHR showed a significant increase in aortic stiffness and blood pressure, which is accompanied by a remarkable cell stiffening and ROCK activation in thoracic aortic (TA) VSMCs. Theses alterations in SHR were abolished by Y-27632, a specific inhibitor of ROCK. Additionally, boosted filamentous/globular actin ratio was detected in TA VSMCs from SHRversus WKY rats, resulting in an up-regulation of SRF and myocardin expression and its downstream stiffness-associated genes including α-smooth muscle actin, SM22, smoothelin and myosin heavy chain 11. Reciprocally, these alterations in SHR TA VSMCs were also suppressed by Y-27632. Furthermore, a specific inhibitor of SRF/myocardin, CCG-100602, showed a similar effect to Y-27632 in SHR in both TA VSMCs stiffness in vitro and aorta wall stiffness in vivo. ROCK is a novel mediator modulating aortic VSMC stiffness through SRF/myocardin signaling which offers a therapeutic target to reduce aortic stiffening in hypertension.
登录
查看更多内容
DOI:
10.1038/nrm2890
发表时间:
2010-05
期刊:
Nature reviews. Molecular cell biology
影响因子:
--
作者:
通讯作者:
--
影响因子:
4.8
作者:
Kureishi, Y;Kobayashi, S;Ito, M
通讯作者:
Ito, M
影响因子:
1.6
作者:
Cecelja M;Chowienczyk P
通讯作者:
Chowienczyk P
DOI:
10.1161/hypertensionaha.114.00921
发表时间:
2014-07
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
Mitchell GF
通讯作者:
Mitchell GF
影响因子:
24
作者:
Pu, Jun;Mintz, Gary S.;Maehara, Akiko
通讯作者:
Maehara, Akiko